The Efficacy of Transversus Abdominis Plane Block After Groin Hernia Repair

November 17, 2011 updated by: Pernille Lykke Petersen, Glostrup University Hospital, Copenhagen

The Efficacy of Transversus Abdominis Plane Block Versus Placebo Versus Local Infiltration in Patients Undergoing Groin Hernia Repair in Day Case Surgery.

The purpose of this study is to determine whether Transversus abdominis plane block is superior to placebo or superior to local infiltration in analgesic efficacy after groin hernia repair.

Study Overview

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glostrup, Denmark, 2600
        • Department of Anaesthesiology, Glostrup University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-75 years old
  • groin hernia repair
  • written consent
  • ASA 1-3
  • BMI 18-35

Exclusion Criteria:

  • unable to communicate in Danish
  • relevant drug allergy
  • pain medication in the last 24 hours
  • pregnancy
  • alcohol or/and drug abuse
  • daily opioid intake
  • infection at injection site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
TAP block with 25 ml of saline Ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline.
UL-guided Tap block with 25 ml of saline single dose Ilioinguinal block with 10 ml of saline and local infiltration with saline 40 ml single dose
Other Names:
  • postoperative pain.
Active Comparator: Local infiltration
Ilioinguinal block with 10 ml of ropivacaine 0,375% Local infiltration with 40 ml of ropivacaine 0,375% Tap block with 25 ml of saline
Ilioinguinal block with 10 ml of ropivacaine 0,375% single dose, local infiltration with 40 ml of ropivacaine 0,375% single dose, UL-guided Tap block with 25 ml of saline single dose
Other Names:
  • Local wound infiltration
Experimental: Transversus abdominis plane block
25 ml of Ropivacaine 0,75%, Ilioinguinal block with 10 ml saline and local infiltration with 40 ml of saline.
UL-guided TAP block with 25 ml of ropivacaine 0,75% unilateral, single dose, ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline
Other Names:
  • postoperative pain, UL-guided block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain scores by coughing between TAP block group and placebo group
Time Frame: 0,2,4,6,8,19 and 24 hours postoperative
Area under the curve (AUC)-pain during cough based on measurements at 0,2,4,6,8,19,24 hours postoperative
0,2,4,6,8,19 and 24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain scores by coughing between placebo and local infiltration and between TAP block and local infiltration.
Time Frame: 0,2,4,6,8,19 and 24 hours postoperative
Area under the curve (AUC)-pain during cough based on measurements 0,2,4,6,8,19,24 hours postoperative.
0,2,4,6,8,19 and 24 hours postoperative
Total opioid consumption
Time Frame: 0-24 hours postoperative
Total morphine consumption 0-2 hours postoperative. Total ketobemidone consumption 2-24 hours postoperative.
0-24 hours postoperative
Postoperative nausea and vomiting
Time Frame: 0,2,4,6,8,19,24 hours postoperative
Levels of nausea (0-3)at 0,2,4,6,8,19,24 hours postoperative Number of vomits 0-2, 2-4, 4-6, 6-8, 8-19 og 19-24 hours postoperative.
0,2,4,6,8,19,24 hours postoperative
Sedation
Time Frame: 0,2,4,6,8,19,24 hours postoperative
Levels of sedation (0-3)at 0,2,4,6,8,19,24 hours postoperative.
0,2,4,6,8,19,24 hours postoperative
Pain scores at rest between TAP block versus placebo and TAP block versus infiltration and infiltration versus placebo
Time Frame: 0,2,4,6,8,19,24 hours postoperative
Area under the curve (AUC)-pain at rest based on measurements at 0,2,4,6,8,19,24 hours postoperative
0,2,4,6,8,19,24 hours postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pernille L Petersen, MD, Glostrup University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

November 1, 2011

Study Registration Dates

First Submitted

January 19, 2010

First Submitted That Met QC Criteria

January 19, 2010

First Posted (Estimate)

January 20, 2010

Study Record Updates

Last Update Posted (Estimate)

November 18, 2011

Last Update Submitted That Met QC Criteria

November 17, 2011

Last Verified

November 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • SM1-plp-10
  • 2010-018403-29 (EudraCT Number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hernia

Clinical Trials on Saline

Subscribe